Dx Deals: Quest Closes PathAI Partial Acquisition and Strategic Alliance
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
From - Laboratory Industry Report
Strategic alliance rather than M&A remains the preferred form of strategic interaction in the lab industry…
From - Laboratory Industry Report
The lab industry consolidated its early 2017 gains with an almost equally strong Q2. Although there were some notable declines, most companies posted gains at or above Wall Street expectations. Here's an overview based on…
By Mike O'Brien bio
Lots of ADA Facility Lawsuits in Utah: Here is an interesting legal news update from my partner Mike Judd: Title III of the Americans with Disabilities Act (ADA) requires places of…
From - Laboratory Industry Report
Consumerism, patient empowerment and affordability are key drivers in the modern medical industry. One of the key manifestations of…
From - G2 Blog
It is a recurrent challenge for human resource professionals: Determining whether an employee is exempt from the overtime requirements of the…
There is a lot of talk about quality these days, but there is often confusion around quality terminology
By Jennifer Dawson, MHA, LSSBB, DLM(ASCP) bio
Now before the entire industry lynches me for the sacrilege of the title of this article, let me explain what I mean. I have known Lean Six Sigma skeptics and outright haters and trust me…